Serplulimab Combined With Nab-paclitaxel and Cisplatin in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

Conditions: Esophageal Squamous Cell Carcinoma Interventions: Drug: Serplulimab Combined With Nab-paclitaxel and Cisplatin; Drug: nab-paclitaxel ，Cisplatin Sponsors: Yang Jianjun, PhD Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials